"
Team:BV CAPS Kansas/Project/Future
From 2013hs.igem.org
(Difference between revisions)
Capsamcclain (Talk | contribs) |
Meaton2222 (Talk | contribs) |
||
| (2 intermediate revisions not shown) | |||
| Line 714: | Line 714: | ||
position: relative; | position: relative; | ||
width: 208px; | width: 208px; | ||
| - | margin-top: | + | margin-top:8px; |
float: right; | float: right; | ||
height: auto; | height: auto; | ||
| Line 1,164: | Line 1,164: | ||
<p>Our plan for future projects!</p> | <p>Our plan for future projects!</p> | ||
| - | In the future, the 2014 iGEM team will be continuing with this project idea, and expanding the use of it. We are hoping to make great improvements next year! < | + | In the future, the 2014 iGEM team will be continuing with this project idea, and expanding the use of it. We are hoping to make great improvements next year!<br><br> <ol> |
<li>Next year, we can make more parts with various promoters and ribosomal binding sites.</li><br> | <li>Next year, we can make more parts with various promoters and ribosomal binding sites.</li><br> | ||
<li>To characterize the parts better, we will be using a pyruvate kinase assay and gas chromatography.</li><br> | <li>To characterize the parts better, we will be using a pyruvate kinase assay and gas chromatography.</li><br> | ||
Latest revision as of 18:50, 21 June 2013
BV CAPS iGEM Tweets
Thanks!
Future
Our plan for future projects!
In the future, the 2014 iGEM team will be continuing with this project idea, and expanding the use of it. We are hoping to make great improvements next year!- Next year, we can make more parts with various promoters and ribosomal binding sites.
- To characterize the parts better, we will be using a pyruvate kinase assay and gas chromatography.
- We also want to examine optimal conditions of cyanobacteria, including experimentation with CO2 limitation to reroute Acetyl-CoA usage in the cell to the alkane pathway.
- Furthermore, we plan on making a more in-depth and accurate TinkerCell model to show the amount of resources directed into specific pathways in the cell and how we are trying to change that usage.
- We would also like to expand our community outreach by expanding a BioBuilder.
